Eslicarbazepine Acetate Tablet
Pricing Report NDC 59651-534-30
Current Package Pricing Information
The current wholesale acquisition cost for Eslicarbazepine Acetate (NDC 59651-534-30) is $1.85082 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 30, 2026.
As a a human prescription drug provided by Aurobindo Pharma Limited, this medication is distributed in a 30 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $1.85082 Per EA
Historical Pricing Trends & Acquisition Cost Benchmarks
The current wholesale price for (NDC ) is based on the most recent federal survey data. As this is a newer entry or has a stable pricing model, the chart below reflects the current established benchmark of $1.85082 per EA.
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Sep 30, 2026 | $1.85082 | EA | C/I - Chain or Independent Pharmacy | Code 1 | G - Generic |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: October 07, 2026
